Company Filing History:
Years Active: 2014-2017
Title: Tim D Cabelka: Innovator in Controlled Release Dosage Forms
Introduction
Tim D Cabelka is a notable inventor based in Midland, MI (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of controlled release dosage forms. With a total of 2 patents to his name, Cabelka's work is recognized for its innovative approach to drug delivery systems.
Latest Patents
Cabelka's latest patents include a granular material designed for dosage forms. This invention focuses on a granular material that has a mean particle diameter of 150 to 350 micrometers. The composition is engineered to produce a dosage form for controlled release, which is achieved through a compact with a tensile strength of at least 1.7 MPa when subjected to a compaction pressure of 266 MPa. Notably, at least 80 percent of the granular material consists of a water-soluble cellulose ether, a water-soluble cellulose ester, an alkylene oxide homo- or copolymer, or a blend thereof, along with an active ingredient.
Career Highlights
Cabelka is currently employed at Dow Global Technologies LLC, where he continues to push the boundaries of innovation in pharmaceutical technology. His work has not only contributed to the advancement of drug delivery systems but has also positioned him as a key player in the industry.
Collaborations
Throughout his career, Cabelka has collaborated with several talented individuals, including Akshay Bellare and Ka Chun A Chan. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Tim D Cabelka's contributions to the field of controlled release dosage forms highlight his innovative spirit and dedication to improving pharmaceutical formulations. His work at Dow Global Technologies LLC and his patents reflect a commitment to advancing drug delivery systems for better patient outcomes.